Gujarat Themis Biosyn Approves QIP, Sets Issue Price at ₹354 Per Share
Gujarat Themis Biosyn Limited closed its QIP issue on August 28, 2026. The issue price is set at ₹354 per equity share, with a discount of 4.98% on the floor price. The company will allot 2,11,86,440 equity shares to QIBs.
A QIP is a significant event for fundraising, which can impact the company's financial structure and growth prospects, hence a medium impact.
The company successfully completed its QIP, setting a specific issue price and closing the period, indicating progress in fundraising.
Gujarat Themis Biosyn Limited announced the outcome of its Fund-Raising Committee meeting held on August 28, 2026. The committee approved the closure of the Qualified Institutions Placement (QIP) issue period on the same day, following the receipt of application forms and funds from eligible Qualified Institutional Buyers (QIBs). The issue price for 2,11,86,440 equity shares has been determined and approved at ₹354 per equity share. This includes a premium of ₹353 per equity share and represents a discount of ₹18.57 per equity share (4.98%) on the floor price of ₹372.57 per equity share, as permitted by SEBI regulations.
The committee also approved and finalized the confirmation of allocation notes for the QIBs and adopted the placement document dated August 28, 2026. This document is available on the company's website, www.gtbl.in. The QIP, which opened on August 25, 2026, saw its Fund-Raising Committee meeting commence at 8:15 p.m. and conclude at 8:30 p.m. on August 28, 2026.
The company has submitted the placement document to the stock exchanges and informed them of these developments in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.